Incidence of anemia, leukocytosis, and thrombocytosis in patients with solid tumors in China
Authors:
- 23 July 2010
- journal article
- research article
- Published by Springer Nature in Tumor Biology
- Vol. 31 (6) , 633-641
Abstract
Despite the fact that malignancies are associated with hematological abnormalities, some clinical studies have been unable to detect such a relation. The aim of our study was to detect the prevalence of pretreatment hematologic abnormalities in patients with common solid tumors and to determine if such a profile could be used for prognostic evaluations. We identified all patients in Cancer Center of Sun Yat-sen University who were diagnosed as solid tumors (breast carcinoma, hepatocellular carcinoma, nasopharyngeal carcinoma, esophageal carcinoma, gastric cancer, cervical carcinoma, endometrial cancer, renal cell carcinoma, and non-small cell lung cancer) between January 2000 and August 2009. All subjects were investigated regarding levels of white blood cells, platelets, and hemoglobin concentration. We identified 3,180 patients with solid tumors and 285 patients with benign diseases for the final analysis. The percentages of leukocytosis, anemia, and thrombocytosis in patients with solid tumors ranged from 4.0% to 25.6%, 3.3% to 29.2%, and 2.1% to 9.7%, respectively. The multivariate Cox analysis revealed that anemia was an independent prognostic factor in patients with breast cancer (P = 0.006), hepatocellular carcinoma (P = 0.002), nasopharyngeal carcinoma (P = 0.008), and esophageal carcinoma (P = 0.001). Leukocytosis was an independent prognostic factor in patients with cervical cancer (P = 0.007). The incidence of hematological abnormalities in Chinese patients with solid tumors was relatively lower than that of the counterparts in the Western countries. A pretreatment anemia or leukocytosis can serve as a useful marker to predict outcome of patients in some of the solid tumors.Keywords
This publication has 36 references indexed in Scilit:
- Prognostic significance of a pretreatment hematologic profile in patients with head and neck cancerJournal of Cancer Research and Clinical Oncology, 2009
- Preoperative hemoglobin and platelet count and poor prognostic factors in patients with endometrial carcinomaJournal of Cancer Research and Clinical Oncology, 2008
- Pre-treatment haemoglobin level predicts response and survival after TPF induction polychemotherapy in advanced head and neck cancer patientsClinical Otolaryngology, 2008
- Prognostic impact of thrombocytosis in resectable non-small cell lung cancerInteractive CardioVascular and Thoracic Surgery, 2008
- Clinical Significance of Platelet Count in Patients with Renal Cell CarcinomaUrologia Internationalis, 2007
- Preoperative thrombocytosis predicts poor survival in patients with glioblastomaNeuro-Oncology, 2007
- The prognostic significance of thrombocytosis in uterine papillary serous carcinomasGynecologic Oncology, 2007
- Pretreatment prognostic factors and treatment outcome in elderly patients with de novo acute myeloid leukemiaAnnals of Oncology, 2005
- Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma1Journal of the American College of Surgeons, 2004
- Prognostic significance of thrombocytosis in patients with primary lung cancerEuropean Respiratory Journal, 1996